Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection.
Regulatory T cells (T(regs)) manipulated ex vivo have potential as cellular therapeutics in autoimmunity and transplantation. Although it is possible to expand naturally occurring T(regs), an attractive alternative possibility, particularly suited to solid organ and bone marrow transplantation, is t...
Główni autorzy: | Feng, G, Nadig, SN, Bäckdahl, L, Beck, S, Francis, R, Schiopu, A, Whatcott, A, Wood, K, Bushell, A |
---|---|
Format: | Journal article |
Język: | English |
Wydane: |
2011
|
Podobne zapisy
-
Cyclic nucleotide phosphodiesterases in health and disease /
od: Beavo, Joe, i wsp.
Wydane: (2007) -
Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model.
od: Issa, F, i wsp.
Wydane: (2010) -
A brief in vitro activation is sufficient to equip naturally-occurring regulatory T Cells to control allograft rejection long-term
od: Chan, T, i wsp.
Wydane: (2014) -
Cyclic nucleotide specific phosphodiesterases of <it>Leishmania major</it>
od: Linder Markus, i wsp.
Wydane: (2006-03-01) -
Role of Cyclic Nucleotide Phosphodiesterases in Inner Ear and Hearing
od: Rahul Mittal, i wsp.
Wydane: (2017-11-01)